Item 7.01  Regulation FD Disclosure
On January 10, 2022, HealthEquity, Inc. (the "Company") issued a press release,
attached as Exhibit 99.1 to this current report on Form 8-K, announcing its
estimated year-end sales results for its fiscal year ending January 31, 2022 and
that it will discuss these results and estimates during its virtual presentation
at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at
4:30 PM Eastern Time. A live audio webcast of the presentation along with a copy
of the Company's presentation material from the conference will be available
through the investor page at the Company website: ir.healthequity.com.
The information in Exhibit 99.1 is being furnished to the Securities and
Exchange Commission and shall not be deemed "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
Item 9.01  Financial Statements and Exhibits
(d) Exhibits
Exhibit No.         Description
99.1                  Press release issued by HealthEquity, Inc. dated January 10, 2022
104                 Cover Page Interactive Data File (formatted in Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses